{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361981469597809792.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1681/asn.v891357"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/00001751-199709000-00001"}},{"identifier":{"@type":"PMID","@value":"9294826"}}],"dc:title":[{"@value":"Urinary excretion of aquaporin-2 water channel protein in human and rat."}],"description":[{"notation":[{"@value":"Previous studies by the authors demonstrated that the response of urinary aquaporin-2 (AQP2) excretion to dDAVP (deamino-8-D-arginine vasopressin) infusion is an index of vasopressin action on the kidney (N Engl J Med 332: 1540-1545, 1995). In the study presented here, the characteristics of urinary excretion of AQP2 were examined further. An RIA suitable for AQP2 in the urine was established. Relatively high concentrations of detergent and bovine serum albumin in the RIA buffer allowed analysis of urine samples with a wide range of concentrations and increased the sensitivity of the assay. AQP2 in the urine existed as a high molecular weight form of approximately 190 kD by HPLC analysis. The mean urinary AQP2 concentration corrected for creatinine in spot urine samples of healthy subjects who voided in the morning was 1081 +/- 699 fmol/mg creatinine (mean +/- SD, n = 208). The amount of daily excretion of AQP2 in the urine was the same in men and women. Urinary AQP2 content was not affected by age of the subjects and showed a positive correlation with urine osmolality. Finally, the fraction of AQP2 excreted in the urine compared with whole kidney content was determined in the rat. Approximately 3% of AQP2 in the kidney was excreted daily, and this fraction did not change when rats were dehydrated for 3 d. These data demonstrate the necessity of establishing well-designed protocols to use urinary AQP2 as a marker of AVP action."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380009582611473923","@type":"Researcher","foaf:name":[{"@value":"T Rai"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809796","@type":"Researcher","foaf:name":[{"@value":"K Sekine"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809793","@type":"Researcher","foaf:name":[{"@value":"K Kanno"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809795","@type":"Researcher","foaf:name":[{"@value":"K Hata"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809792","@type":"Researcher","foaf:name":[{"@value":"M Miura"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809797","@type":"Researcher","foaf:name":[{"@value":"A Mizushima"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809664","@type":"Researcher","foaf:name":[{"@value":"F Marumo"}]},{"@id":"https://cir.nii.ac.jp/crid/1381981469597809798","@type":"Researcher","foaf:name":[{"@value":"S Sasaki"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"10466673"}],"prism:publicationName":[{"@value":"Journal of the American Society of Nephrology"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"1997-09","prism:volume":"8","prism:number":"9","prism:startingPage":"1357","prism:endingPage":"1362"},"reviewed":"false","dcterms:accessRights":"http://purl.org/coar/access_right/c_abf2","url":[{"@id":"https://journals.lww.com/00001751-199709000-00001"}],"createdAt":"2021-04-26","modifiedAt":"2023-03-02","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Adult","dc:title":"Adult"},{"@id":"https://cir.nii.ac.jp/all?q=Male","dc:title":"Male"},{"@id":"https://cir.nii.ac.jp/all?q=Aquaporin%202","dc:title":"Aquaporin 2"},{"@id":"https://cir.nii.ac.jp/all?q=Dehydration","dc:title":"Dehydration"},{"@id":"https://cir.nii.ac.jp/all?q=Radioimmunoassay","dc:title":"Radioimmunoassay"},{"@id":"https://cir.nii.ac.jp/all?q=Middle%20Aged","dc:title":"Middle Aged"},{"@id":"https://cir.nii.ac.jp/all?q=Aquaporins","dc:title":"Aquaporins"},{"@id":"https://cir.nii.ac.jp/all?q=Aquaporin%206","dc:title":"Aquaporin 6"},{"@id":"https://cir.nii.ac.jp/all?q=Ion%20Channels","dc:title":"Ion Channels"},{"@id":"https://cir.nii.ac.jp/all?q=Rats","dc:title":"Rats"},{"@id":"https://cir.nii.ac.jp/all?q=Rats,%20Sprague-Dawley","dc:title":"Rats, Sprague-Dawley"},{"@id":"https://cir.nii.ac.jp/all?q=Reference%20Values","dc:title":"Reference Values"},{"@id":"https://cir.nii.ac.jp/all?q=Animals","dc:title":"Animals"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Female","dc:title":"Female"},{"@id":"https://cir.nii.ac.jp/all?q=Chromatography,%20High%20Pressure%20Liquid","dc:title":"Chromatography, High Pressure Liquid"},{"@id":"https://cir.nii.ac.jp/all?q=Aged","dc:title":"Aged"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004232352077696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aquaporin 2: From its discovery to molecular structure and medical implications"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706909488640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Regulation of Aquaporins by Vasopressin in the Kidney"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285711305435904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Excretion of urinary exosomal AQP2 in rats is regulated by vasopressin and urinary pH"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643837521664","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181214409344","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urinary excretion of the water channel aquaporin 2 correlated with the pharmacological effect of tolvaptan in cirrhotic patients with ascites"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567189446332928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092787472256","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Effect of Increased Daily Water Intake and Hydration on Health in Japanese Adults"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679317074048","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"シクロスポリンにより部分腎性尿崩症を発症した頻回再発型ネフローゼ症候群の1 男児例"},{"@language":"en","@value":"A case report of transient partial nephrogenic diabetes insipidus with steroid-dependent nephrotic syndrome during cyclosporine treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680083579904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Awareness of the Vasopressin System in Heart Failure"},{"@value":"Increased Urine Aquaporin-2 Relative to Plasma Arginine Vasopressin Is a Novel Marker of Response to Tolvaptan in Patients With Decompensated Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680203246592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Tolvaptan Prolongs Blockage of the Vasopressin Type II Receptor Over 24 Hours in Responders With Stage D Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680203352192","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Aquaporin-2-Guided Tolvaptan Therapy in Patients With Congestive Heart Failure Accompanied by Chronic Kidney Disease"},{"@value":"Effect of Tolvaptan in Patients With Chronic Kidney Disease Due to Diabetic Nephropathy With Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942143693056","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Daily variance of urinary excretion of AQP2 determined by sandwich ELISA method"}]},{"@id":"https://cir.nii.ac.jp/crid/2050870367074117632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Decreased expression of aquaporin 2 in the collecting duct of mice lacking the vasopressin V1a receptor"}]},{"@id":"https://cir.nii.ac.jp/crid/2051433317027841408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Alkali treatment stabilizes fluctuations of urine AQP2 values measured by ELISA"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1681/asn.v891357"},{"@type":"OPENAIRE","@value":"doi_dedup___::8eb1e3374634064286faa3163bb2aaa2"},{"@type":"CROSSREF","@value":"10.1007/s10157-011-0574-2_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1007/s10157-012-0686-3_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1536/ihj.15-297_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1016/j.ekir.2021.06.033_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.3390/nu12041191_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1152/ajprenal.00249.2013_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1016/bs.vh.2014.12.008_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.3165/jjpn.cr.2017.0112_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1016/j.mam.2012.03.004_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1007/s00535-015-1143-3_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1007/s10157-015-1176-1_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-0244_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.3390/ijms17010105_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"},{"@type":"CROSSREF","@value":"10.1536/ihj.14-217_references_DOI_QwyvTn9jYWFh7Nef8XU9WO71rd9"}]}